A carregar...
Analysis of Clinical Predictive Factors Affecting the Outcome of Second-Line Chemotherapy for Gemcitabine-Refractory Advanced Pancreatic Cancer
BACKGROUND/AIMS: The benefit of second-line chemotherapy (SL) after failed first-line chemotherapy (FL) in patients with advanced pancreatic cancer has not yet been established. We evaluated the clinical characteristics affecting the benefits of SL compared to best supportive care (BSC), identified...
Na minha lista:
| Publicado no: | Gut Liver |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Editorial Office of Gut and Liver
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6974334/ https://ncbi.nlm.nih.gov/pubmed/30974927 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl18419 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|